icd 10 code for squamous cell carcinoma in situ icd 10 code for squamous cell carcinoma in situ

If an entity wishes to utilize any AHA materials, please contact the AHA at 312‐893‐6816. Complete absence of all Bill Types indicates Making copies or utilizing the content of the UB‐04 Manual, including the codes and/or descriptions, for internal purposes, without the written consent of the AHA. Abnormal cells are found in the lower part of the epidermis (the outer layer of the skin). In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Subject to the terms and conditions contained in this Agreement, you, your employees and agents are authorized to use CDT only as contained in the following authorized materials and solely for internal use by yourself, employees and agents within your organization within the United States and its territories. C44.12- Squamous cell carcinoma of skin of eyelid, including canthus By clicking below on the button labeled "I accept", you hereby acknowledge that you have read, understood and agreed to all terms and conditions set forth in this agreement. that coverage is not influenced by Revenue Code and the article should be assumed to apply equally to all Revenue Codes. The AMA is a third party beneficiary to this Agreement. Other risk factors for SCC include: To assign the most appropriate ICD-10-CM code for squamous cell carcinoma, clinical documentation should indicate: ICD-10-CM chapter 2 contains codes for most benign and malignant neoplasms. 635 0 obj <>stream In most instances Revenue Codes are purely advisory. End User Point and Click Amendment: damages arising out of the use of such information, product, or process. You are leaving the CMS MCD and are being redirected to the CMS MCD Archive that contains outdated (No Longer In Effect) Local Coverage Determinations and Articles, You are leaving the CMS MCD and are being redirected to, Billing and Coding: Destruction of Malignant Skin Lesions, AMA CPT / ADA CDT / AHA NUBC Copyright Statement, Article - Billing and Coding: Destruction of Malignant Skin Lesions (A57638). However, services performed for any given diagnosis must meet all of the indications and limitations stated in the LCD, the general requirements for medical necessity as stated in CMS payment policy manuals, any and all existing CMS national coverage determinations, and all Medicare payment rules. 7500 Security Boulevard, Baltimore, MD 21244. Copyright 2023, AAPC SCC is the most common malignancy of the conjunctiva in the US, with a yearly incidence of 1-2.8 per 100,000. S. Create your account. Therefore, if a drug is self-administered by more than 50 percent of Medicare beneficiaries, the drug is excluded from coverage" and the MAC will make no payment for the drug. The submitted CPT/HCPCS code must describe the service performed. Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes. If the "INDICATOR" is set to "2" these records were re -reviewed and over road the rules from ICD-O-3 code book. Breast codes for ICD-10-CM include sex along with laterality. This page displays your requested Article. The documentation must include the legible signature of the physician or non-physician practitioner responsible for and providing the care to the patient. CMS has defined "not usually self-administered" according to how the Medicare population as a whole uses the drug, not how an individual patient or physician may choose to use a particular drug. Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes. . M0: no clinical or radiographic evidence of distant metastasis. This Agreement will terminate upon notice if you violate its terms. Primary malignant neoplasms overlapping site boundaries. A Draft article will eventually be replaced by a Billing and Coding article once the Proposed LCD is released to a final LCD. We did one shave biopsy and the path report came back as Inflamed AK with extremely focal areas of squamous cell carcinoma in situ. The AMA does not directly or indirectly practice medicine or dispense medical services. Also, you can decide how often you want to get updates. recipient email address(es) you enter. Refer to the LCD for reasonable and necessary requirements and limitations. CDT is a trademark of the ADA. Response to Comment (RTC) articles list issues raised by external stakeholders during the Proposed LCD comment period. The development of SCCis has also been associated with immunosuppression . However, please note that once a group is collapsed, the browser Find function will not find codes in that group. The patient is informed that the biopsy results confirm squamous cell carcinoma. Neither the United States Government nor its employees represent that use of such information, product, or processes Current Dental Terminology © 2022 American Dental Association. MACs are Medicare contractors that develop LCDs and Articles along with processing of Medicare claims. See page 66 in ICD-O-3. C44.72- Squamous cell carcinoma of skin of lower limb, including hip Primary squamous-cell carcinoma of the thyroid shows an aggressive biological phenotype . q_r7ds1A"TTD`3i6`q@Jia$D/ %]/_ Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (, malignant neoplasm of skin of genital organs (, Primary malignant neoplasm of skin of breast. Oncology. Cutaneous SCC is an invasive disease, referring to cancer cells that have grown beyond the epidermis. CPT codes, descriptions and other data only are copyright 2022 American Medical Association. Billing and Coding articles provide guidance for the related Local Coverage Determination (LCD) and assist providers in submitting correct claims for payment. C44.02 Squamous cell carcinoma of skin of lip You agree to take all necessary steps to insure that your employees and agents abide by the terms of this agreement. resale and/or to be used in any product or publication; creating any modified or derivative work of the UB‐04 Manual and/or codes and descriptions; 2. Use of CDT is limited to use in programs administered by Centers for Medicare & Medicaid Services (CMS). For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CDT for resale and/or license, transferring copies of CDT to any party not bound by this agreement, creating any modified or derivative work of CDT, or making any commercial use of CDT. Notice: It is not appropriate to bill Medicare for services that are not covered (as described by the entire LCD) as if they are covered. %%EOF Medicare contractors are required to develop and disseminate Articles. The Medicare program provides limited benefits for outpatient prescription drugs. An ambiguous, but moderate to high suspicion lesion would be excised with moderate to wide surrounding grossly normal skin/soft tissue margins, as for a malignant lesion. Refers to a mixed tumor containing both adenocarcinoma and squamous cell carcinoma, wherein each of these cell types comprise at least 10% of the tumor volume. Primary malignant neoplasms overlapping site boundaries. Basal cell carcinoma of skin, unspecified. Primary malignant neoplasms overlapping site boundaries. Revenue Codes are equally subject to this coverage determination. About 90% of cases of head and neck cancer (cancer of the mouth, nasal cavity, nasopharynx, throat and associated structures) are due to SCC.. The following ICD-10-CM codes support medical necessity and provide limited coverage for CPT codes: 11620, 11621, 11622, 11623, 11624, and 11626. Please enable "JavaScript" and revisit this page or proceed with browsing CMS.gov with Before sharing sensitive information, make sure you're on a federal government site. For purpose of this exclusion, "the term 'usually' means more than 50 percent of the time for all Medicare beneficiaries who use the drug. will not infringe on privately owned rights. ICD-10-CM Coding instruction note: Excludes familial polycythemia (C75.0), secondary polycythemia (D75.1) D46.- Myelodysplastic syndromes . See page 66 in ICD-O-3. If you are experiencing any technical issues related to the search, selecting the 'OK' button to reset the search data should resolve your issues. The redetermination process may be utilized for consideration of services performed outside of the reasonable and necessary requirements in the LCD. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. GOVERNMENT AND ITS EMPLOYEES ARE NOT LIABLE FOR ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION, PRODUCT, OR PROCESSES Subscribe to Codify by AAPC and get the code details in a flash. CMS believes that the Internet is This would be most appropriately reported using the excision of benign lesion codes 11400-11446. This First Coast Billing and Coding Article for Local Coverage Determination (LCD) L33813 Destruction of Malignant Skin Lesions provides billing and coding guidance for frequency limitations as well as diagnosis limitations that support diagnosis to procedure code automated denials. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Note: . CeAe?Es=p+PdM#KH B1)dV m}T*^-!>_H {%| ApL'%n(^}p,3HaKYl8mR Uem#pgC Aq_f`L}daP? Applications are available at the American Dental Association web site. In a few cases, such as for malignant melanoma and certain . Notice: It is not appropriate to bill Medicare for services that are not covered (as described by the entire LCD) as if they are covered. 604 0 obj <> endobj Use of CDT is limited to use in programs administered by Centers for Medicare & Medicaid Services (CMS). Contractors may specify Bill Types to help providers identify those Bill Types typically The submitted medical record must support the use of the selected ICD-10-CM code(s). Article document IDs begin with the letter "A" (e.g., A12345). If you would like to extend your session, you may select the Continue Button. article does not apply to that Bill Type. The Table of Neoplasms should be used to identify the correct topography code. It is the providers responsibility to select codes carried out to the highest level of specificity and selected from the ICD-10-CM code book appropriate to the year in which the service is rendered for the claim(s) submitted. You agree to take all necessary steps to insure that your employees and agents abide by the terms of this agreement. The AMA does not directly or indirectly practice medicine or dispense medical services. The CMS.gov Web site currently does not fully support browsers with CMS and its products and services are not endorsed by the AHA or any of its affiliates. Billing and Coding articles typically include CPT/HCPCS procedure codes, ICD-10-CM diagnosis codes, as well as Bill Type, Revenue, and CPT/HCPCS Modifier codes. You can collapse such groups by clicking on the group header to make navigation easier. This section shows you chapter-specific coding guidelines to increase your understanding and correct usage of the target ICD-10-CM Volume 1 code. Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT for resale and/or license, transferring copies of CPT to any party not bound by this agreement, creating any modified or derivative work of CPT, or making any commercial use of CPT. Draft articles are articles written in support of a Proposed LCD. The scope of this license is determined by the AMA, the copyright holder. C44.12: Squamous cell carcinoma of skin of eyelid, including canthus. ICD 10 code for Squamous cell carcinoma of skin of upper limb, including shoulder. Should the foregoing terms and conditions be acceptable to you, please indicate your agreement and acceptance by clicking below on the button labeled "I Accept". An additional code from Chapter 4 may be used, to identify functional . An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Response to Comment (RTC) articles list issues raised by external stakeholders during the Proposed LCD comment period. Medicaid and the State Children's Health Insurance Programs, contracts with certain organizations to assist in the administration This email will be sent from you to the Sign up to get the latest information about your choice of CMS topics in your inbox. ICD-10-CM Codes that Support Medical Necessity, ICD-10-CM Codes that DO NOT Support Medical Necessity, L33818 - Excision of Malignant Skin Lesions, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 0.5 CM OR LESS, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 0.6 TO 1.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 1.1 TO 2.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 2.1 TO 3.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 3.1 TO 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER OVER 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 0.5 CM OR LESS, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 0.6 TO 1.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 1.1 TO 2.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 2.1 TO 3.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 3.1 TO 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER OVER 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 0.5 CM OR LESS, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 0.6 TO 1.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 1.1 TO 2.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 2.1 TO 3.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 3.1 TO 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER OVER 4.0 CM, Malignant melanoma of other part of trunk, Malignant melanoma of unspecified upper limb, including shoulder, Malignant melanoma of right upper limb, including shoulder, Malignant melanoma of left upper limb, including shoulder, Malignant melanoma of unspecified lower limb, including hip, Malignant melanoma of right lower limb, including hip, Malignant melanoma of left lower limb, including hip, Merkel cell carcinoma of other part of trunk, Merkel cell carcinoma of unspecified upper limb, including shoulder, Merkel cell carcinoma of right upper limb, including shoulder, Merkel cell carcinoma of left upper limb, including shoulder, Merkel cell carcinoma of unspecified lower limb, including hip, Merkel cell carcinoma of right lower limb, including hip, Merkel cell carcinoma of left lower limb, including hip, Unspecified malignant neoplasm of anal skin, Unspecified malignant neoplasm of skin of breast, Unspecified malignant neoplasm of skin of other part of trunk, Basal cell carcinoma of skin of other part of trunk, Squamous cell carcinoma of skin of breast, Squamous cell carcinoma of skin of other part of trunk, Other specified malignant neoplasm of anal skin, Other specified malignant neoplasm of skin of breast, Other specified malignant neoplasm of skin of other part of trunk, Unspecified malignant neoplasm of skin of unspecified upper limb, including shoulder, Unspecified malignant neoplasm of skin of right upper limb, including shoulder, Unspecified malignant neoplasm of skin of left upper limb, including shoulder, Basal cell carcinoma of skin of unspecified upper limb, including shoulder, Basal cell carcinoma of skin of right upper limb, including shoulder, Basal cell carcinoma of skin of left upper limb, including shoulder, Squamous cell carcinoma of skin of unspecified upper limb, including shoulder, Squamous cell carcinoma of skin of right upper limb, including shoulder, Squamous cell carcinoma of skin of left upper limb, including shoulder, Other specified malignant neoplasm of skin of unspecified upper limb, including shoulder, Other specified malignant neoplasm of skin of right upper limb, including shoulder, Other specified malignant neoplasm of skin of left upper limb, including shoulder, Unspecified malignant neoplasm of skin of unspecified lower limb, including hip, Unspecified malignant neoplasm of skin of right lower limb, including hip, Unspecified malignant neoplasm of skin of left lower limb, including hip, Basal cell carcinoma of skin of unspecified lower limb, including hip, Basal cell carcinoma of skin of right lower limb, including hip, Basal cell carcinoma of skin of left lower limb, including hip, Squamous cell carcinoma of skin of unspecified lower limb, including hip, Squamous cell carcinoma of skin of right lower limb, including hip, Squamous cell carcinoma of skin of left lower limb, including hip, Other specified malignant neoplasm of skin of unspecified lower limb, including hip, Other specified malignant neoplasm of skin of right lower limb, including hip, Other specified malignant neoplasm of skin of left lower limb, including hip, Malignant neoplasm of unspecified upper limb, Malignant neoplasm of unspecified lower limb, Malignant neoplasm of other specified ill-defined sites, Melanoma in situ of breast (skin) (soft tissue), Melanoma in situ of unspecified upper limb, including shoulder, Melanoma in situ of right upper limb, including shoulder, Melanoma in situ of left upper limb, including shoulder, Melanoma in situ of unspecified lower limb, including hip, Melanoma in situ of right lower limb, including hip, Melanoma in situ of left lower limb, including hip, Carcinoma in situ of skin of unspecified upper limb, including shoulder, Carcinoma in situ of skin of right upper limb, including shoulder, Carcinoma in situ of skin of left upper limb, including shoulder, Carcinoma in situ of skin of unspecified lower limb, including hip, Carcinoma in situ of skin of right lower limb, including hip, Carcinoma in situ of skin of left lower limb, including hip, Unspecified malignant neoplasm of skin of scalp and neck, Basal cell carcinoma of skin of scalp and neck, Squamous cell carcinoma of skin of scalp and neck, Other specified malignant neoplasm of skin of scalp and neck, Malignant neoplasm of overlapping sites of vulva, Malignant neoplasm of other specified female genital organs, Malignant neoplasm of overlapping sites of female genital organs, Malignant neoplasm of overlapping sites of penis, Malignant neoplasm of head, face and neck, Secondary malignant neoplasm of genital organs, Carcinoma in situ of skin of scalp and neck, Carcinoma in situ of unspecified female genital organs, Carcinoma in situ of other female genital organs, Carcinoma in situ of unspecified male genital organs, Carcinoma in situ of other male genital organs, Malignant neoplasm of external lip, unspecified, Malignant neoplasm of upper lip, inner aspect, Malignant neoplasm of lower lip, inner aspect, Malignant neoplasm of lip, unspecified, inner aspect, Malignant neoplasm of commissure of lip, unspecified, Malignant neoplasm of overlapping sites of lip, Malignant neoplasm of dorsal surface of tongue, Malignant neoplasm of ventral surface of tongue, Malignant neoplasm of anterior two-thirds of tongue, part unspecified, Malignant neoplasm of overlapping sites of tongue, Malignant neoplasm of tongue, unspecified, Malignant neoplasm of anterior floor of mouth, Malignant neoplasm of lateral floor of mouth, Malignant neoplasm of overlapping sites of floor of mouth, Malignant neoplasm of floor of mouth, unspecified, Malignant neoplasm of overlapping sites of palate, Malignant neoplasm of palate, unspecified, Malignant neoplasm of overlapping sites of unspecified parts of mouth, Malignant neoplasm of overlapping sites of other parts of mouth, Malignant neoplasm of submandibular gland, Malignant neoplasm of major salivary gland, unspecified, Malignant neoplasm of tonsillar pillar (anterior) (posterior), Malignant neoplasm of overlapping sites of tonsil, Malignant neoplasm of tonsil, unspecified, Malignant neoplasm of anterior surface of epiglottis, Malignant neoplasm of lateral wall of oropharynx, Malignant neoplasm of posterior wall of oropharynx, Malignant neoplasm of overlapping sites of oropharynx, Malignant neoplasm of oropharynx, unspecified, Malignant neoplasm of superior wall of nasopharynx, Malignant neoplasm of posterior wall of nasopharynx, Malignant neoplasm of lateral wall of nasopharynx, Malignant neoplasm of anterior wall of nasopharynx, Malignant neoplasm of overlapping sites of nasopharynx, Malignant neoplasm of nasopharynx, unspecified, Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect, Malignant neoplasm of posterior wall of hypopharynx, Malignant neoplasm of overlapping sites of hypopharynx, Malignant neoplasm of hypopharynx, unspecified, Malignant neoplasm of pharynx, unspecified, Malignant neoplasm of overlapping sites of lip, oral cavity and pharynx, Malignant melanoma of unspecified eyelid, including canthus, Malignant melanoma of right upper eyelid, including canthus, Malignant melanoma of right lower eyelid, including canthus, Malignant melanoma of left upper eyelid, including canthus, Malignant melanoma of left lower eyelid, including canthus, Malignant melanoma of unspecified ear and external auricular canal, Malignant melanoma of right ear and external auricular canal, Malignant melanoma of left ear and external auricular canal, Malignant melanoma of unspecified part of face, Malignant melanoma of other parts of face, Malignant melanoma of overlapping sites of skin, Merkel cell carcinoma of unspecified eyelid, including canthus, Merkel cell carcinoma of right upper eyelid, including canthus, Merkel cell carcinoma of right lower eyelid, including canthus, Merkel cell carcinoma of left upper eyelid, including canthus, Merkel cell carcinoma of left lower eyelid, including canthus, Merkel cell carcinoma of unspecified ear and external auricular canal, Merkel cell carcinoma of right ear and external auricular canal, Merkel cell carcinoma of left ear and external auricular canal, Merkel cell carcinoma of unspecified part of face, Merkel cell carcinoma of other parts of face, Merkel cell carcinoma of overlapping sites, Unspecified malignant neoplasm of skin of lip, Other specified malignant neoplasm of skin of lip, Unspecified malignant neoplasm of skin of unspecified eyelid, including canthus, Unspecified malignant neoplasm of skin of right upper eyelid, including canthus, Unspecified malignant neoplasm of skin of right lower eyelid, including canthus, Unspecified malignant neoplasm of skin of left upper eyelid, including canthus, Unspecified malignant neoplasm of skin of left lower eyelid, including canthus, Basal cell carcinoma of skin of unspecified eyelid, including canthus, Basal cell carcinoma of skin of right upper eyelid, including canthus, Basal cell carcinoma of skin of right lower eyelid, including canthus, Basal cell carcinoma of skin of left upper eyelid, including canthus, Basal cell carcinoma of skin of left lower eyelid, including canthus, Squamous cell carcinoma of skin of unspecified eyelid, including canthus, Squamous cell carcinoma of skin of right upper eyelid, including canthus, Squamous cell carcinoma of skin of right lower eyelid, including canthus, Squamous cell carcinoma of skin of left upper eyelid, including canthus, Squamous cell carcinoma of skin of left lower eyelid, including canthus, Sebaceous cell carcinoma of skin of unspecified eyelid, including canthus, Sebaceous cell carcinoma of skin of right upper eyelid, including canthus, Sebaceous cell carcinoma of skin of right lower eyelid, including canthus, Sebaceous cell carcinoma of skin of left upper eyelid, including canthus, Sebaceous cell carcinoma of skin of left lower eyelid, including canthus, Other specified malignant neoplasm of skin of unspecified eyelid, including canthus, Other specified malignant neoplasm of skin of right upper eyelid, including canthus, Other specified malignant neoplasm of skin of right lower eyelid, including canthus, Other specified malignant neoplasm of skin of left upper eyelid, including canthus, Other specified malignant neoplasm of skin of left lower eyelid, including canthus, Unspecified malignant neoplasm of skin of unspecified ear and external auricular canal, Unspecified malignant neoplasm of skin of right ear and external auricular canal, Unspecified malignant neoplasm of skin of left ear and external auricular canal, Basal cell carcinoma of skin of unspecified ear and external auricular canal, Basal cell carcinoma of skin of right ear and external auricular canal, Basal cell carcinoma of skin of left ear and external auricular canal, Squamous cell carcinoma of skin of unspecified ear and external auricular canal, Squamous cell carcinoma of skin of right ear and external auricular canal, Squamous cell carcinoma of skin of left ear and external auricular canal, Other specified malignant neoplasm of skin of unspecified ear and external auricular canal, Other specified malignant neoplasm of skin of right ear and external auricular canal, Other specified malignant neoplasm of skin of left ear and external auricular canal, Unspecified malignant neoplasm of skin of unspecified part of face, Unspecified malignant neoplasm of skin of nose, Unspecified malignant neoplasm of skin of other parts of face, Basal cell carcinoma of skin of unspecified parts of face, Basal cell carcinoma of skin of other parts of face, Squamous cell carcinoma of skin of unspecified parts of face, Squamous cell carcinoma of skin of other parts of face, Other specified malignant neoplasm of skin of unspecified parts of face, Other specified malignant neoplasm of skin of nose, Other specified malignant neoplasm of skin of other parts of face, Unspecified malignant neoplasm of overlapping sites of skin, Basal cell carcinoma of overlapping sites of skin, Squamous cell carcinoma of overlapping sites of skin, Other specified malignant neoplasm of overlapping sites of skin, Carcinoma in situ of oral cavity, unspecified site, Carcinoma in situ of labial mucosa and vermilion border, Carcinoma in situ of gingiva and edentulous alveolar ridge, Melanoma in situ of unspecified eyelid, including canthus, Melanoma in situ of right upper eyelid, including canthus, Melanoma in situ of right lower eyelid, including canthus, Melanoma in situ of left upper eyelid, including canthus, Melanoma in situ of left lower eyelid, including canthus, Melanoma in situ of unspecified ear and external auricular canal, Melanoma in situ of right ear and external auricular canal, Melanoma in situ of left ear and external auricular canal, Melanoma in situ of unspecified part of face, Carcinoma in situ of skin of unspecified eyelid, including canthus, Carcinoma in situ of skin of right upper eyelid, including canthus, Carcinoma in situ of skin of right lower eyelid, including canthus, Carcinoma in situ of skin of left upper eyelid, including canthus, Carcinoma in situ of skin of left lower eyelid, including canthus, Carcinoma in situ of skin of unspecified ear and external auricular canal, Carcinoma in situ of skin of right ear and external auricular canal, Carcinoma in situ of skin of left ear and external auricular canal, Carcinoma in situ of skin of unspecified part of face, Carcinoma in situ of skin of other parts of face, Some older versions have been archived.